ESMO Preceptorship on Prostate Cancer Prague June 2016

Oncology Meeting Resources

23 Jun - 24 Jun, Prague, Czech Republic

ESMO Preceptorship on Prostate Cancer

The ESMO Preceptorship on Prostate Cancer Prague October 2016 was designed for learning about fundamentals of epidemiology, natural history and diagnosis as contributing factors to heterogeneity in prostate cancer; understanding essentials in the assessment and multidisciplinary treatment of prostate cancer; learning about advances in treatment and novel targets in prostate cancer.

Presentations of the ESMO Preceptorship on Prostate Cancer Prague October 2016 are available to ESMO members according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only.

ESMO thanks the authors for their generosity.

 

Useful links

Presenter Presentation title Session title
A. Horwich, UK Active Surveillance Localized Prostate Cancer
A. Horwich, UK Conclusion and Farewell Novel Therapies
E. Kassouf, CA Metastatic Prostate Cancer Clinical Case Novel Therapies
L. Bei, PT Clinical Case Study Novel Therapies
A. V. Silva, PT Metastatic Prostate Cancer: Which Prognostic Factors? Advanced Prostate Cancer
E. Castro, ES First and Second-Line Chemotherapy Advanced Prostate Cancer
K. Fizazi, FR Immunotherapy and Other New Drug Targets Novel Therapies
K. Fizazi, FR Bone Targeting (Bisphosphonates and RANK Ligands) Novel Therapies
R. L. Mejorada, ES Radium-223 in Chemo-Naive Castration-Resistant Prostate Cancer Castration Resistant Prostate Cancer (CRPC)
H. R. Kourie, BE Castration Failure of Prostate Cancer Presented with Hemorragic Carcinomatous Meningitis Castration Resistant Prostate Cancer (CRPC)
A. Horwich, UK Isotope Therapies and Palliative Radiotherapy Castration Resistant Prostate Cancer (CRPC)
K. Fizazi, FR Next Generation Androgen Receptor Axis Inhibitors Castration Resistant Prostate Cancer (CRPC)
K. Wdowiak, PL Metastatic Prostate Cancer Advanced Prostate Cancer
A. Mislang, IT Treatment Considerations in an Elderly Man with Advanced Castrate Resistant Prostate Cancer Advanced Prostate Cancer
A. Horwich, UK First-line Hormone Therapy for Metastatic Disease; Role and Toxicities Advanced Prostate Cancer